期刊文献+

泛素特异性蛋白酶在头颈部鳞状细胞癌中的研究进展 被引量:1

Research Progress of Ubiquitin-Specific Pep-tidases in Head and Neck Squamous Cell Carcinoma
下载PDF
导出
摘要 头颈部鳞状细胞癌(head and neck squamous cell carcinoma, HNSCC)是一种高度侵袭性和增殖性的肿瘤,其五年生存率较低,主要原因是对HNSCC的发病机制认识不清,缺乏有效的治疗手段。泛素特异性蛋白酶(ubiquitin-specific peptidases, USPs)是去泛素化酶家族的主要成员,能够识别特定蛋白质的泛素化信号,从而使靶蛋白去泛素化,进而参与细胞增殖、分化、凋亡和迁移等多种生物学功能。在这篇综述中,我们将对一些USPs在HNSCC发生发展中的作用进行阐述,为HNSCC的诊断和靶向治疗奠定基础。 Head and neck squamous cell carcinoma (HNSCC) is a highly invasive and proliferative tumor with a low five-year survival rate, mainly due to the poor understanding of the pathogenesis of HNSCC and the lack of effective treatment. The ubiquitin-specific peptidases (USPs) are the main member of the deubiquitinase family. The USPs involve in multiple biological processes including cell proliferation, differentiation, apoptosis and migration by specially recognizing and removing ubiquitin chain of target proteins. In this review, we will elaborate on the role of some USPs in tumorigenesis and progression of HNSCC, in order to lay the foundation for the diagnosis and targeted therapy of HNSCC.
出处 《临床医学进展》 2022年第10期9596-9604,共9页 Advances in Clinical Medicine
  • 相关文献

参考文献5

二级参考文献50

  • 1Al-Hajj M,Wicha MS,Benito-hernandez A,et al.Prospective identification of tumorigenic breast cancer cells[J].Proc Natl Acad Sci USA,2003,100(7):3983-3988.
  • 2Prince ME,Sivanandan R,Kaczorowski A,et al.Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma[J].Pro Natl Acad Sci USA,2007,104(3):973-978.
  • 3Zhou L,Wei X,Cheng L,et al.CD133,one of the markers of cancer stem cells in Hep-2cell line[J].Laryngoscope,2007,117 (3):455-460.
  • 4Zhang XY,Pfeiffer HK,Thome AW,et al.USP22,an hSAGA subunit and potential cancer stem cell marker,reverses the polycomb-catalyzed ubiquitylation of histone H2A[J].Cell Cycle,2008,7 (11):1522-1524.
  • 5Zhang XY,Varthi M,Sykes SM,et al.The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression[J].Mol Cell,2008,29(1):102-111.
  • 6Li J,Wang Z,Li Y.USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma[J].J Cancer Res Clin Oncol,2012,138 (8):1291-1297.
  • 7van der Kooy D,Weiss S.Why stem cell?[J].Science,2000,287 (5457):1439-1441.
  • 8Glinsky GV.Death-from-cancer signatures and stem cell contribution to metastatic cancer[J].Cell Cycle,2005,4 (9):1171-1175.
  • 9Glinsky GV.Genomic models of metastatic cancer:functional analysis of death-from-cancer signature genes reveals aneuploid,anoikisresistant,metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway[J].Cell Cycle,2006,5 (11):1208-1216.
  • 10Lee HJ,Kim MS,Shin JM,et al.The expression patterns of deubiquitinating enzymes,USP22 and Usp22[J].Gene Expr Patterns,2006,6(3):277-284.

共引文献20

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部